A Phase I study evaluating the safety and immunogenicity of MVA85A, a candidate TB vaccine, in HIV-infected adults

Angela M Minassian ,Ian Poulton ,Richard A Koup ,Brenna J Hill ,Jackie Sherrard ,Joseph P Casazza ,David Ambrozak ,Nicola Williams ,Rosalind Rowland ,Kristin Griffiths ,Jonathan Ross ,Matthew M Hamill ,Stephanie A Harris ,Hazel C Poyntz ,Iman Satti ,Daniel C Douek ,David Ashley Price ,Ansar A Pathan ,Mario Roederer ,Clare R Sander ,Natalie E R Beveridge ,Alan Winston ,G Rooney ,Alison M Lawrie ,Helen A Fletcher ,Helen Mcshane

doi:10.1136/bmjopen-2011-000223

A Phase I study evaluating the safety and immunogenicity of MVA85A, a candidate TB vaccine, in HIV-infected adults

Angela M Minassian , Ian Poulton + Show 24 more

Open Access

https://doi.org/10.1136/bmjopen-2011-000223

Copy DOI

Journal: BMJ Open	Publication Date: Jan 1, 2011
Citations: 43	License type: open-access

Affiliation: Jenner Institute, University of Oxford, National Institutes of Health, National Institute of Allergy and Infectious Diseases, Churchill Hospital, Selly Oak Hospital, University Hospitals Birmingham NHS Foundation Trust, Cardiff University, Brunel University London, Imperial College Healthcare NHS Trust, Great Western Hospital, Great Western Hospitals NHS Foundation Trust

#Safety Of MVA85A #HIV-uninfected Subjects + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

ObjectivesControl of the tuberculosis (TB) epidemic is a global health priority and one that is likely to be achieved only through vaccination. The critical overlap with the HIV epidemic requires...

Full Text

Paper version not known

Open DOI Link

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title

Journal

Date

Author

View more papers

More From: BMJ Open

Paper Title

Journal

Date

Author

View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.